We reviewed the literature to study the clinical features, the managem
ent and the outcome of meningeal chondrosarcomas. We included 31 patie
nts in this review: 22 were mesenchymal and nine were non-mesenchymal.
The mean age was 27 years and 64% arose from the cranial meninges. Th
e treatment was mainly total surgical excision. Adjuvent therapy was g
iven to 36% of patients. Spinal meningeal chondrosarcomas had a better
prognosis (81% 1-year survival and 45% 3-year survival). There were n
o pathognomonic clinical or radiological features. We concluded that t
he best management of meningeal chondrosarcomas is total surgical exci
sion whenever possible, followed by combined course of radiotherapy an
d chemotherapy as soon as possible.